This article gives an overview of the medications for cystic fibrosis. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are a class of medications that help improve the ...

RCT-2100 is under clinical development by Recode Therapeutics and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase II drugs for Cystic Fibrosis have a 31% phase transition ...

Update on evaluation of cystic fibrosis transmembrane conductance regulator modulator therapies and continued patient access (November 2023) Responding to the National Institute for Health and Care ...

Results CF neutrophils live longer due to decreased apoptosis. This was observed in both cystic fibrosis transmembrane conductance regulator (CFTR) null piglets and patients with CF, and furthermore ...

Galicaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

The less than 10 per cent blocked were either deemed as unnecessary or did not meet security standards, according to the update from the Cyberspace Administration of China (CAC). “Most projects ...

A new charity football team in Peterborough has been set up to honour the memory of Jordan Smith and raise awareness of Cystic Fibrosis. Jordan Smith (25) passed away at the beginning of November ...

The corporate regulator released for public comment the proposed amendments, draft guidelines and rules on registrars of qualified institutional and individual buyers; crypto-asset service providers ...